National Institute for Health and Clinical Excellence (NICE)
*Aged 29 years and under - aged 30 - 39 years at moderate risk of breast cancer - aged 30 - 49 years who have not had genetic testing but have a greater than 30% probability of being a TP53 carrier - of any age with a known TP53 mutation.
National Institute for Health and Clinical Excellence (NICE)
*Women: -of any age at moderate risk of breast cancer - of any age at high risk of breast cancer but with a 30% or lower probability of being a BRCA or TP53 carrier - aged 20‰??29 years who have not had genetic testing but have a greater than 30% probability of being a BRCA carrier - aged 20‰??29 years with a known BRCA1 or BRCA2 mutation - aged 50‰??69 years who have not had genetic testing but have a greater than 30% probability of being a BRCA or a TP53 carrier, unless mammography has ...
National Institute for Health and Clinical Excellence (NICE)
*But consider it: -when MRI surveillance would normally be offered but is not suitable (for example, because of claustrophobia) - when results of mammography or MRI are difficult to interpret.
